Eficácia de um produto à base de oxigênio ativo no tratamento não cirúrgico da Mucosite peri-implantar

Abstract

Peri-implant mucositis is an inflammatory condition without loss of bone tissue, which occurs in the soft tissues around the implant. Non-surgical treatment combines basic periodontal therapy with or without the use of chemical agents. The objective of this study was to evaluate the efficacy of the active oxygen (Bluem®) as a chemical adjuvant in the non-surgical treatment of peri-implant mucositis. Twenty implants in 9 patients were ramdomly treated, 9 in the test group (Bluem®) and 11 in the control group (placebo), in individuals rehabilitated with dental implants. Peri-implant clinical parameters of visible plaque index (VPI), gingival bleeding index (GBI), probing depth (PD), bleeding on probing (BOP) and keratinized mucosa were evaluated at baseline and one and six months. For the statistical analysis, Mann-Whitney, Friedman, Wilcoxon and Fisher's Exact tests were used with a significance level of 5%. The results showed that there was a statistical decrease for full mouth VPI (56.81% to 27.27%) and full mouth GBI (32.95% to 28.41%) of the test group; full mouth VPI (42.86% to 15.18%) and full mouth GBI (31.25% to 2.32%) of the control group; Implant VPI in the control group (21.42% to 0%); probing depth for the test group (2.83mm to 2mm) and BOP for the control group (33.33% to 16.67%). However, there were no significant differences between the two groups. It can be concluded that Bluem can be used as a chemical adjuvant in the treatment of peri-implant mucositis.